Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
GVAX vs. Placebo for MDS/AML After Allo HSCT
- Status
- TERMINATED
- Phase
- PHASE2
Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)
- Status
- TERMINATED
- Phase
- N/A
the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient
- Status
- UNKNOWN
- Phase
- PHASE3
Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
DC Vaccination for Postremission Therapy in AML
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant
- Status
- COMPLETED
- Phase
- PHASE2
A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001)
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study of DFP-10917 in Patients With Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Busulfan and Cyclophosphamide Followed By ALLO BMT
- Status
- TERMINATED
- Phase
- NA
A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving
- Status
- COMPLETED
- Phase
- PHASE1
Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT
- Status
- COMPLETED
- Phase
- N/A
Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2